La Jolla, CA, United States of America

Reuben J Shaw

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • San Diego, CA (US) (2015)
  • La Jolla, CA (US) (2019 - 2020)

Company Filing History:


Years Active: 2015-2020

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Reuben J Shaw: Innovator in Therapeutic Methods

Introduction

Reuben J Shaw is a prominent inventor based in La Jolla, California. He has made significant contributions to the field of biological studies, particularly in the development of therapeutic methods. With a total of four patents to his name, Shaw's work focuses on innovative approaches to treating various diseases.

Latest Patents

Among his latest patents, Shaw has developed ULK1 inhibitors and methods using the same. This invention provides a method for treating a disease or condition in a subject. The method involves co-administering a therapeutically effective amount of at least one ULK1-inhibiting pyrimidine alongside an mTOR inhibitor. This dual approach aims to enhance treatment efficacy for patients in need.

Career Highlights

Shaw has had a distinguished career, working at notable institutions such as the Salk Institute for Biological Studies and the Sanford Burnham Prebys Medical Discovery Institute. His research has been pivotal in advancing our understanding of therapeutic interventions in biological sciences.

Collaborations

Throughout his career, Shaw has collaborated with esteemed colleagues, including Daniel F Egan and Nicholas Cosford. These partnerships have contributed to the success and impact of his research endeavors.

Conclusion

Reuben J Shaw's innovative work in developing ULK1 inhibitors showcases his commitment to advancing medical science. His contributions continue to influence therapeutic methods and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…